SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-002291
Filing Date
2022-02-28
Accepted
2022-02-28 16:12:02
Documents
13
Period of Report
2022-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acad-20220228.htm   iXBRL 8-K 52005
2 EX-99.1 acad-ex99_1.htm EX-99.1 286267
  Complete submission text file 0000950170-22-002291.txt   469225

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acad-20220228_lab.xml EX-101.LAB 13466
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acad-20220228_pre.xml EX-101.PRE 9908
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acad-20220228.xsd EX-101.SCH 2499
7 EXTRACTED XBRL INSTANCE DOCUMENT acad-20220228_htm.xml XML 4760
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 22689612
SIC: 2834 Pharmaceutical Preparations